The first treatment based on CRISPR technology is poised to win FDA approval next month, offering hope to patients and opportunities to investors. "A turning point in medicine" Scientists have made significant progress in treating thousands of illnesses over the years, but finding cures for rare and deadly diseases remains a significant challenge. While treatments for inherited conditions like sickle cell...
Beam Therapeutics股票讨论
出售 🔴\\ $Zoom视频通讯(ZM.US)$ $天宝导航公司(TRMB.US)$ $Twist Bioscience(TWST.US)$ $UiPath(PATH.US)$
• 编辑基因 | $CRISPR Therapeutics(CRSP.US)$ , $Intellia Therapeutics(NTLA.US)$ , $Beam Therapeutics(BEAM.US)$ , $Verve Therapeutics(VERV.US)$ , $Editas Medicine(EDIT.US)$
• 创建疗法 | $Prime Medicine(PRME.US)$ , $Sana Biotechnology(SANA.US)$
• 构建 DNA | $Twist Bioscience(TWST.US)$ , $Ginkgo Bioworks(DNA.US)$ , $Pacific Biosciences of California(PACB.US)$ , $Illumina(ILMN.US)$
• 磁盘...
以下是该行业的一些顶级股票,这些股票因药物试验和财报新闻而上涨:
$Janux Therapeutics (JANX.US) $该公司公布了两个临床项目的最新临床数据,市值超过15.0亿美元,此后,股价飙升了205%,至36.00美元。
$Ligand Pharmicals (LGND.US) $上涨了 23%...
"A turning point in medicine"
Scientists have made significant progress in treating thousands of illnesses over the years, but finding cures for rare and deadly diseases remains a significant challenge. While treatments for inherited conditions like sickle cell...
道琼斯· 4 分钟前
道琼斯· 2 分钟前
暂无评论